# Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment

> **NCT02535572** · PHASE2,PHASE3 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 48 (actual)

## Conditions studied

- Depression

## Interventions

- **DEVICE:** FEAST
- **DEVICE:** RUL UB

## Key facts

- **NCT ID:** NCT02535572
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-06-10
- **Final completion:** 2019-06-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02535572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02535572, "Focal Electrically-Administered Seizure Therapy (FEAST) Studies at Two Enrolling Sites to Further Test and Refine the Treatment". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02535572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*